Sir, Training problems in trabeculectomy
We read with interest the paper by Troutbeck et al. 1 There are not many articles published so far showing the outcome of the trainee and consultant's trabeculectomies. We recently carried out a study on this subject.
We agree that with the new antiglaucoma medications, the need for the trabeculectomy is reduced. The cases that require trabeculectomy are usually either not responding to maximum medical treatment or not suitable for it due to side effects, medical comorbidities, or poor compliance. Therefore, these cases are challenging. Troutbeck et al 1 mentioned in their study that the trainee performed trabeculectomies as a sole operator with or without supervision. Direct supervision throughout the trabeculectomy should improve the technique as well as predict and reduce early postoperative complications.
We note in this study that the trainee commonly performed phacotrabeculectomies or trabeculectomy with antimetabolites (5 flurouracil: 36 cases, mitomycin C: 21 cases). It would be interesting to know the outcomes of the trabeculectomies without antimetabolites. In this paper, it seems trainee and consultants operated on almost equal number of cases who required mitomycin C (21 and 20, respectively) although it is mentioned that these cases were exclusively performed by consultants. Use of antimetabolites is more often associated with early and late postoperative complications (eg, hypotony, increased incidence of bleb interventions and corneal toxicity). This affects long-term intraocular pressure (IOP) control. Therefore, these cases are best managed by experienced surgeons.
In this study, the trainee performed only 1.6 trabeculectomies per year. Our departmental audit in Scotland showed that the trainee performed 6-12 trabeculectomies per year. We agree with Sir, Response to Drs Vani and Delvin Many thanks for your letter regarding our article on trabeculectomy training challenges. It is not surprising that our concerns are worldwide and will result in progressive deskilling of general trained ophthalmologists.
You raise a number of important points. We greatly believe in supervision of the trainees and nearly all would be operating under supervision (although possibly the supervising consultant did not get recorded). Postoperative supervision of the management post trabeculectomy is also just as critical. The number of trabeculectomies with mitomycin C performed by trainees was actually one (not 21) and thus were mostly performed by consultants. The subsets of IOP p15 mmHg outcomes were trabeculectomy (41%), trabeculectomy with 5FU (39%) and phacotrabeculectomy (38%). We suspect the similar results depends on case selectionF phacotrabeculectomies tend to have less severe glaucoma compared with the augmented trabeculectomies that tend to have the more difficult to control glaucoma.
The 'success rate' of 30% was set quite strictly, being defined as p15 mmHg on no medication following the traditional trabeculectomy technique. We agree with better techniques such as fornix-based conjunctival flaps, preplaced removable scleral trapdoor sutures, careful use of mitomycin C, and meticulous conjunctival edge closure outcomes can be improved. Unfortunately the trainees have limited number of cases and will probably require further glaucoma fellowship training to reach satisfactory surgical standard.
GA Lee and R Troubeck
City Eye Centre, Brisbane, Queensland, Australia E-mail: eye@cityeye.com.au Sir, Awareness and the use of nutritional supplementation for age-related macular degeneration patients We read with interest the article 'Awareness and the use of nutritional supplementation for age-related macular degeneration (AMD) patients' by Waisbourd et al. 1 The authors reported that their 'AMD patients lack knowledge about their own ocular disease.' The authors, however, erroneously stated that 'other studies conducted internationally demonstrated lack of awareness for this blinding disease among the general population with 9.2-30% who were not familiar with the disease.' 1 In fact, only 9.2-30% were familiar with the condition as a cause for loss of vision. [2] [3] [4] Singapore has been organising an AMD Awareness Week annually since 2005 in conjunction with AMD Alliance International, a global non-profit coalition of vision, research, and senior organisations working to raise awareness of AMD, its treatment and rehabilitation options, and the importance of early detection. During the AMD Awareness Week, numerous educational talks on AMD, patient support group meetings and eye screenings are conducted at a number of participating hospitals, community centres, libraries, private ophthalmology clinics, and optometry outlets across the country. Amsler charts are also displayed in many public places, and have included trains of the mass rapid transit system ( Figure 1 ) and possibly the largest Amsler chart in the world on a commercial building (Figure 2 ). There is
